1607PD - Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy

Autor: Chawla, S.P., Pollack, S., Block, M., Druta, M., Do, K., Morris, J.C., Kim, J.W., Bohac, C., Lu, H., Gnjatic, S., Jones, R.L., Hwu, P., Somaiah, N.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect